-
More than the third batch of national procurement volume, trillion market will start "big waves of sand
Time of Update: 2020-07-17
"Pharmaceutical Network Industry Dynamics" not long ago, the Beijing Municipal Health Insurance Bureau issued a notice, requiring medical institutions to the third batch of national collection of var
-
Practice pharmacist's important pre-test tips come
Time of Update: 2020-07-09
▍ finishing: Xiyu this year to apply for the examination of the practice of pharmacists candidates note, Chinese the examination website to release pre-test tips On June 4, , the Chinese examination
-
Iranian scientists develop HIV-control drugs over five years
Time of Update: 2020-07-08
, February 3, , Iranian Health Minister Kamran Bagheri Rancrani said Iranian scientists have developed drugs to control the AIDS virus, the ," Rianovosti reported The drug is a made from medicina
-
Xi'an: Living "artificial skin" application clinical
Time of Update: 2020-07-06
the 4th Military Medical University in Xi'an, the successful development of live "artificial skin" has been officially entered into clinical application Using advanced technology, human skin tissue
-
Zebtini officially approved for listing in China
Time of Update: 2020-06-15
On June 3, the State Drug Administration announced that it had approved the listing of the class 1 innovative drug Zebutinib (zanubrutinib) for adult set cell lymphoma (MCL) patients who have previous
-
Pfizer announces innovation target drug Dozerun ® (Dacotinib) approved by China's National Drug Administration
Time of Update: 2020-06-09
recently, Pfizer (http:// announced that the innovative target of drug (http:// Dozerun ® (Dacostinib) on May 15 was approved by the State administration of Medicines and http:// Regulatory
-
FDA grants Roche's preferred review
Time of Update: 2020-06-07
, Roche announced that the u.S FDA (http:// has accepted and qualified for priority review of new drug (http:// About Risdiplam Risdiplam is an mRNA shear modifier for the SMN2 gene for spin
-
China Pharmaceutical Network will participate in the 46th National New Special Drug Fair
Time of Update: 2020-06-04
Business Agency June 9, 2011 July 13-15, the 46th National Special Drug Fair came to The nanjing, known as "Gangnam Jialidi, Jinling Imperial State" reputation With its long history and outstan
-
Merck releases strong 108-week data on evobrutinib multiple sclerosis
Time of Update: 2020-05-30
The latest data show that evobrutinib is the first BTK inhibitor to report up to 108 weeks of efficacy and safety data on the treatment of MS evobrutinib is the first and only BTK inhibitor to show a
-
Medical representatives visit doctors These 13 things must be avoided
Time of Update: 2020-05-18
A few days ago, Dami to the small partners to share the "medical representative visit 8 tips", from the feedback, although a few years ago, Dami shared a lot of visiting tips, but the needs and applic
-
Yulin Normal College holds acceptance meeting on mental health education and consultation demonstration construction
Time of Update: 2020-05-13
On the morning of November 12, Yulin Normal College held the construction acceptance meeting of Guangxi university students' mental health education and consultation demonstration center in the secon
-
Speed up the progress of drug registration and approval and promote the development of the pharmaceutical industry
Time of Update: 2020-05-12
" At present, the drug registration review still has the problem of slow progress, low efficiency and over-time limit, which seriously restricts the enthusiasm of research and development investment
-
April 20, another province of drug price reduction! Message stoist third round with volume purchase
Time of Update: 2020-04-20
Pharmaceutical Network Industry Dynamics: The inflated price of drugs has always been a hot and difficult issue of concern to the masses, to a certain extent, increased the cost of medical treatment
-
Some new drug approval policies are expected to be issued within this year to speed up the review
Time of Update: 2020-04-03
In response to the industry's long-standing appeal that the speed of new drug review and approval is too slow, insiders involved in the formulation of new drug approval policies of the drug administra
-
Weigh! The "consistency assessment" of vaccines is coming
Time of Update: 2019-12-24
Yigu news, today (December 24), in order to further standardize and improve the level of vaccine clinical research and development, and strengthen the supervision of vaccine quality and safety, the St
